Delivery Order SPE2DB22D2206-SPE2DB25FJD72
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,751.91 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml pharmaceutical product, with a completion date of July 25, 2025. This is a firm fixed price, non-set-aside contract awarded on July 24, 2025, with performance to be executed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to...
- The U.S. Defense Logistics Agency (DLA) awarded a $27,203.88 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of TREMFYA 100 MG/ML INJECTORML pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and medical supplies from...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $8,962.95 to AmerisourceBergen Drug Corp for the supply of TREMFYA 200 mg/20 mL vials. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of August 20, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a delivery order valued at $7,255.25 to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 mL pen (2 mL), a pharmaceutical product for military and federal healthcare use. This non-set-aside, competitively awarded contract carries a firm fixed price structure and is scheduled for completion by July 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is registered in the System for Award Management...
- This is a $26,182.78 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product, with a period of performance through July 8, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
- This is a $12,274.15 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for TREMFYA 100 MG/ML ONE-PRESS syringes, with a period of performance through July 7, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global...
- This is a $14,611.15 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of TREMFYA 100 MG/ML ONE-PRESS ML medical products. The delivery order has an ultimate completion date of June 11, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM) with a focus on supplying a wide range of pharmaceutical and medical products to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,080.84 contract is for the supply of TREMFYA 100 MG/ML INJECTORML, a medication, with a period of performance through April 10, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which serves as a comprehensive global pharmaceutical support vehicle...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $8,315.82 firm-fixed-price delivery order contract (SPE2DX23F6MVB) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TREMFYA 100 MG/ML SYRINGEML. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (SPE2DX15D1053) between Amerisourcebergen and DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $13,125.47, is for the supply of TREMFYA 100 MG/ML ONE-PRESSML, a pharmaceutical product. The contract has an ultimate completion date of June 12, 2025 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJD72Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,255.25 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a pharmaceutical product, with a completion date of July 31, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement typical of the agency's medical supply procurement practices. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and running through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 7/30/25 |